168 related articles for article (PubMed ID: 31151028)
1. Molecular and cytogenetic characteristics of myeloid malignancies following luminal gastrointestinal cancer.
Epstein-Peterson ZD; Devlin SM; Stein EM; Klimek VM; Saltz LB; Tallman MS
Leuk Res; 2019 Jul; 82():19-23. PubMed ID: 31151028
[TBL] [Abstract][Full Text] [Related]
2. Translocations between the long arms of chromosomes 1 and 5 in hematologic malignancies are strongly associated with neoplasms of the myeloid lineages.
Johansson B; Brøndum-Nielsen K; Billström R; Schiødt I; Mitelman F
Cancer Genet Cytogenet; 1997 Dec; 99(2):97-101. PubMed ID: 9398862
[TBL] [Abstract][Full Text] [Related]
3. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution.
Santana-Davila R; Holtan SG; Dewald GW; Ketterling RP; Knudson RA; Hanson CA; Steensma DP; Tefferi A
Leuk Res; 2008 Mar; 32(3):407-11. PubMed ID: 17707907
[TBL] [Abstract][Full Text] [Related]
5. Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis.
Christiansen DH; Andersen MK; Pedersen-Bjergaard J
J Clin Oncol; 2001 Mar; 19(5):1405-13. PubMed ID: 11230485
[TBL] [Abstract][Full Text] [Related]
6. Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies.
Giagounidis AA; Germing U; Aul C
Clin Cancer Res; 2006 Jan; 12(1):5-10. PubMed ID: 16397017
[TBL] [Abstract][Full Text] [Related]
7. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of del(20q) in patients with hematological malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
[TBL] [Abstract][Full Text] [Related]
9. Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited.
Jerez A; Gondek LP; Jankowska AM; Makishima H; Przychodzen B; Tiu RV; O'Keefe CL; Mohamedali AM; Batista D; Sekeres MA; McDevitt MA; Mufti GJ; Maciejewski JP
J Clin Oncol; 2012 Apr; 30(12):1343-9. PubMed ID: 22370328
[TBL] [Abstract][Full Text] [Related]
10. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.
Reddi DM; Lu CM; Fedoriw G; Liu YC; Wang FF; Ely S; Boswell EL; Louissaint A; Arcasoy MO; Goodman BK; Wang E
Am J Clin Pathol; 2012 Dec; 138(6):855-66. PubMed ID: 23161720
[TBL] [Abstract][Full Text] [Related]
11. Isolated del(5q) in Patients Following Therapies for Various Malignancies May Not All Be Clinically Significant.
Tang G; Goswami RS; Liang CS; Bueso-Ramos CE; Hu S; DiNardo C; Medeiros LJ
Am J Clin Pathol; 2015 Jul; 144(1):78-86. PubMed ID: 26071464
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Sweet Syndrome in patients with acute myeloid leukemia.
Kazmi SM; Pemmaraju N; Patel KP; Cohen PR; Daver N; Tran KM; Ravandi F; Duvic M; Garcia-Manero G; Pierce S; Nazha A; Borthakur G; Kantarjian H; Cortes J
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):358-363. PubMed ID: 25630528
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia with del(9q) is characterized by frequent mutations of NPM1, DNMT3A, WT1 and low expression of TLE4.
Herold T; Metzeler KH; Vosberg S; Hartmann L; Jurinovic V; Opatz S; Konstandin NP; Schneider S; Zellmeier E; Ksienzyk B; Graf A; Krebs S; Blum H; Cristina Sauerland M; Büchner T; Berdel WE; Wörmann BJ; Mansmann U; Hiddemann W; Bohlander SK; Spiekermann K; Greif PA
Genes Chromosomes Cancer; 2017 Jan; 56(1):75-86. PubMed ID: 27636548
[TBL] [Abstract][Full Text] [Related]
14. [Necessity of Genetic Examination in Treatment for Hematological Malignancies].
Kiyoi H
Rinsho Byori; 2015 Mar; 63(3):369-76. PubMed ID: 26524860
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
[TBL] [Abstract][Full Text] [Related]
16. TP53 and therapy-related myeloid neoplasms.
Chung J; Sallman DA; Padron E
Best Pract Res Clin Haematol; 2019 Mar; 32(1):98-103. PubMed ID: 30927980
[TBL] [Abstract][Full Text] [Related]
17. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
[TBL] [Abstract][Full Text] [Related]
18. Therapy-related myeloid neoplasms in lymphoma survivors: Reducing risks.
Al-Juhaishi T; Khurana A; Shafer D
Best Pract Res Clin Haematol; 2019 Mar; 32(1):47-53. PubMed ID: 30927975
[TBL] [Abstract][Full Text] [Related]
19. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
Larson RA; Le Beau MM
Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
[TBL] [Abstract][Full Text] [Related]
20. Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms.
Schnittger S; Bacher U; Haferlach C; Alpermann T; Dicker F; Sundermann J; Kern W; Haferlach T
Leukemia; 2011 Apr; 25(4):615-21. PubMed ID: 21233837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
